Department of Neuroscience and Ageing Biology, Division of Toxicology and Experimental Medicine, CSIR-Central Drug Research Institute, Lucknow 226031, India; Academy of Scientific & Innovative Research (AcSIR), CSIR-Central Drug Research Institute, India.
Cellular and Molecular Neurobiology Unit, Indian Institute of Technology, Jodhpur, Rajasthan 342011, India.
Cell Signal. 2021 May;81:109922. doi: 10.1016/j.cellsig.2021.109922. Epub 2021 Jan 20.
The study was conducted to assess the role of eukaryotic initiation factor 2 (eIF2α) in progressive dopaminergic neuronal death employing various interventions (YM08, 4μ8C, AEBSF, salubrinal, ursolic acid) of endoplasmic reticulum (ER) stress signaling. The protein level of all the ER stress related signaling factors (GRP78, IRE1α, ATF6, eIF2α, ATF4, XBP-1, GADD153) were estimated after 3 and 7 day of experiment initiation. Findings with single administration of interventions showed that salubrinal exhibited significant protection against rotenone induced adverse alterations in comparison to other interventions. Therefore, further study was expanded with repeat dose of salubrinal. Rotenone administration in rat brain caused the significant biochemical alterations, dose dependent progressive neuronal apoptosis and altered neuronal morphology which was significantly attenuated with salubrinal treatment. In conclusion, findings showed that rotenone administration caused the dose dependent progressive neuronal death including cardinal role of eIF2α, suggesting the potential pharmacological utilization of salubrinal or salubrinal like molecules in therapeutics of Parkinson's diseases.
本研究旨在评估真核起始因子 2(eIF2α)在通过内质网(ER)应激信号的各种干预(YM08、4μ8C、AEBSF、salubrinal、熊果酸)中对进行性多巴胺能神经元死亡的作用。在实验开始后 3 和 7 天,测定了所有 ER 应激相关信号因子(GRP78、IRE1α、ATF6、eIF2α、ATF4、XBP-1、GADD153)的蛋白水平。单次给药干预的结果表明,与其他干预措施相比,salubrinal 对鱼藤酮诱导的不良反应具有显著的保护作用。因此,进一步扩大了 salubrinal 的重复剂量研究。鱼藤酮在大鼠大脑中的给药导致了显著的生化改变、剂量依赖性进行性神经元凋亡和神经元形态改变,salubrinal 处理显著减轻了这些改变。总之,研究结果表明,鱼藤酮给药导致了剂量依赖性进行性神经元死亡,包括 eIF2α 的主要作用,提示 salubrinal 或类似 salubrinal 的分子在帕金森病治疗中的潜在药理学应用。